- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Do | Oculis Holding AG: Oculis Publishes Results of 2025 Annual General Meeting | 100 | ZUG, Switzerland, June 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) ("Oculis" or the "Company"), today announced the results from its 2025 Annual General Meeting held on... ► Artikel lesen | ||
| Do | Capgemini SE: Capgemini becomes an Official Partner of the Tour de France and Tour de France Femmes avec Zwift until 2029 to power cycling through tech and innovation | 120 | Capgemini press contact: Victoire Grux Tel.:+33 6 04 52 16 55E-mail: victoire.grux@capgemini.com Tour de France press contacts: Fabrice Tiano - ftiano@aso.fr - +33 6 33 86 28 64Mélanie Vallage - mvallage@aso.fr... ► Artikel lesen | ||
| Do | Atos International: Atos to deliver key IT services and applications for UEFA Nations League Finals 2025 | 248 | Press Release
Atos to deliver key IT services and applications for UEFA Nations League Finals 2025
Paris, France - 5 June, 2025... ► Artikel lesen | ||
| Do | Alvotech and Dr. Reddy's Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda (pembrolizumab) | 126 | HYDERABAD, INDIA & REYKJAVIK, ICELAND (June 5, 2025) - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide... ► Artikel lesen | ||
| Do | Panostaja Oyj: Panostaja Oyj's Half Year Financial Report November 1, 2024-April 30, 2025 | 43 | 5.6.2025 10:00:00 EEST | Panostaja Oyj |
Half Year financial report
Panostaja Oyj Half Year Financial Report June 5, 2025 10.00 a.m.
Panostaja Oyj's Half Year Financial Report November... ► Artikel lesen | ||
| Do | Guard Therapeutics International AB: Guard Therapeutics announces completion of patient enrollment in Phase 2b POINTER study | 42 | Guard Therapeutics (publ) today announced that the last patient has been successfully enrolled in the company's ongoing Phase 2b clinical trial, POINTER, evaluating the drug candidate RMC-035 as a kidney-protective... ► Artikel lesen | ||
| Do | Compagnie Financière Richemont SA: Richemont publishes FY25 Annual Report and Non-Financial Report | 277 | 5 JUNE 2025
RICHEMONT PUBLISHES FY25 ANNUAL REPORT AND NON-FINANCIAL REPORT
Richemont has today published its combined Annual Report and Accounts with the Business review, the Compensation... ► Artikel lesen | ||
| Do | Ageas Re partners with Slovenian insurer Triglav Group in connection with the Motor insurance business distributed by Italian Insurtech Prima | 433 | Ageas Re partners with Slovenian insurer Triglav Group in connection with the Motor insurance business distributed by Italian Insurtech Prima
Today, Ageas Re, the reinsurance arm of Ageas Group... ► Artikel lesen | ||
| Do | Safello Group AB: Safello increases exposure to TAO in its strategic crypto reserve | 321 | Stockholm, 5 June 2025 | Safello, the leading cryptocurrency exchange in the Nordics, today announces a fifth reallocation of its crypto treasury, further increasing exposure to TAO, the native token... ► Artikel lesen | ||
| Do | Klimator AB: Klimator receives expanded order from Mesta AS - strengthens winter maintenance in Norway with smart technology in a deal worth SEK 1.5 million | 34 | The order includes the delivery and implementation of Klimator's decision support software Road Status Information (RSI) across an additional six maintenance areas, along with more that 100 IoT-based... ► Artikel lesen | ||
| Do | Triodos Bank N.V.: Triodos Bank intends to list Depository Receipts on Euronext Amsterdam as of 18 June 2025 | 51 | Triodos Bank N.V. (Triodos Bank) announces that the listing and trading of its Depository Receipts on Euronext Amsterdam (the "Listing") will commence on 18 June 2025 under the symbol TRIO, barring... ► Artikel lesen | ||
| Do | Facephi to Host Investor Day in Madrid on June 18, 2025 | 191 | Facephi to Host Investor Day in Madrid
Alicante, June 04, 2025 - Facephi Biometría, SA (BME Growth: FACE; Euronext Growth Paris: ALPHI) ("Facephi" or the "Company"), a Spanish technology leader... ► Artikel lesen | ||
| Do | Valantic: valantic FSA names Holger Wohlenberg as new CEO | 268 | Capital market infrastructure specialist brings extensive leadership experience to drive next phase of growth strategyFrankfurt, Germany, June 05, 2025 (GLOBE NEWSWIRE) -- valantic FSA, a leading provider... ► Artikel lesen | ||
| Do | Kalmar Corporation: Kalmar hybrid straddle carriers selected to expand capacity at French Seayard Terminal | 242 | KALMAR CORPORATION, PRESS RELEASE, 5 JUNE 2025 AT 9:00 AM (EEST)
Kalmar hybrid straddle carriers selected to expand capacity at French Seayard Terminal
Kalmar has concluded a deal to supply... ► Artikel lesen | ||
| Do | EssilorLuxottica signs an agreement to acquire A-Look, Seen and OWL retail stores in Malaysia | 94 | EssilorLuxottica signs an agreement to acquireA-Look, Seen and OWL retail stores in Malaysia With this transaction, the Group aims at further elevating the standards of vision care in the country... ► Artikel lesen | ||
| Do | Ignitis grupe: 313.7 MW Kelme wind farm in Lithuania has reached the commercial operation date, after completion of second stage | 86 | AB "Ignitis grupe" (hereinafter - the Group) informs that Kelme wind farm II, controlled?by its subsidiary UAB "Ignitis renewables" (hereinafter - Ignitis Renewables), has reached the commercial operation... ► Artikel lesen | ||
| Do | QLife Holding AB: Qlife enters letter of intent with Hipro Biotechnology Co., Ltd. to join forces through a reverse takeover | 32 | Qlife Holding AB ("Qlife" or the "Company") has entered into a non-binding letter of intent ("Letter of Intent") with Hipro Biotechnology Co., Ltd., registration no. 91130100794182204D, ("Hipro") regarding... ► Artikel lesen | ||
| Do | Kancera AB: Kancera reports positive outcome of pre-IND meeting with FDA | 30 | Kancera AB (publ) (Kancera) today reports that it has completed a successful pre-IND meeting with the FDA and received positive feedback on the planned clinical development program for KAND567 in ST-elevation... ► Artikel lesen | ||
| Do | VALLOUREC OBTAINS THE QUALIFICATION OF ITS HYDROGEN STORAGE SOLUTION AND LAUNCHES COMMERCIALIZATION | 287 | Press Release
VALLOUREC OBTAINS THE QUALIFICATION OF ITS HYDROGEN STORAGE SOLUTION AND LAUNCHES COMMERCIALIZATION
Meudon (France), June 5, 2025 - Vallourec, a world leader in premium seamless... ► Artikel lesen | ||
| Do | Basilea Pharmaceutica AG: Strong Cresemba (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea | 203 | Allschwil, Switzerland, June 05, 2025
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial... ► Artikel lesen | ||
| Do | Astrivax: AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology | 244 | Third asset to advance into clinical trials, validating broad potential of Launch-iT platformAll subjects treated with first dose of AVX70371 Launch-iT, as part of multiple dosing schedule Potential... ► Artikel lesen | ||
| Do | Addex Therapeutics: Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference | 251 | Geneva, Switzerland, June 5, 2025
-
Addex Therapeutics(SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators... ► Artikel lesen | ||
| Do | Planisware expands into Belgium to support the sustained growth of its business in the Benelux region | 45 | Planisware expands into Belgium to support the sustained growth of its business in the Benelux region Paris, France, June 5, 2025 - Planisware, a leading B2B provider of SaaS in the rapidly growing... ► Artikel lesen | ||
| Do | ICA Gruppen AB: ICA Gruppen's report for first four months of 2025 | 30 | Press release
Solna
5 June 2025ICA Gruppen's report for the first four months shows a strengthened market position, while continuing investments in price adversely impacted earnings for ICA Sweden.... ► Artikel lesen | ||
| Do | Burckhardt Compression AG: Burckhardt Compression continues to deliver strong growth and increased profitability | 283 | Ad hoc announcement pursuant to Art. 53 LR of June 5th, 2025
Winterthur, June 5th, 2025
Burckhardt Compression achieved the following record results in fiscal year 2024:Sales of CHF 1'095.6... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .